These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 12818283

  • 1. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, Mandal SK, Ray S, Dasgupta S.
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [Abstract] [Full Text] [Related]

  • 2. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [Abstract] [Full Text] [Related]

  • 3. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW, Kalk JF, Klein CP.
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [Abstract] [Full Text] [Related]

  • 4. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S, Castaño G, García SI, Viudez P, González C, Pirola CJ.
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [Abstract] [Full Text] [Related]

  • 5. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ.
    J Gastroenterol; 2003 Mar; 38(12):1150-4. PubMed ID: 14714252
    [Abstract] [Full Text] [Related]

  • 6. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
    Agasti AK, Mahajan AU, Phadke AY, Nathani PJ, Sawant P.
    J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
    [Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
    Escorsell A, Bordas JM, Castañeda B, Llach J, García-Pagán JC, Rodés J, Bosch J.
    Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 10. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.
    Wagatsuma Y, Naritaka Y, Shimakawa T, Kanako H, Keiichiro I, Shunichi S, Konno S, Katsube T, Ogawa K.
    Hepatogastroenterology; 2006 Jul; 53(68):171-4. PubMed ID: 16608017
    [Abstract] [Full Text] [Related]

  • 11. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S, Kawafune T, Suzuki T, Kubota M, Okajima T, Sumino Y, Akita H.
    Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
    [Abstract] [Full Text] [Related]

  • 12. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM, Popescu CR.
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J.
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [Abstract] [Full Text] [Related]

  • 14. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
    Castaño G, Viudez P, Riccitelli M, Sookoian S.
    Ann Hepatol; 2003 Mar; 2(1):36-40. PubMed ID: 15094704
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 16. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G.
    J Clin Gastroenterol; 2007 May; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [Abstract] [Full Text] [Related]

  • 17. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K, Nakayama T, Saito M, Hatano H, Tsukamoto T, Terabayashi H, Sugita S, Wada K, Nomura F, Koen H.
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [Abstract] [Full Text] [Related]

  • 19. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
    Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.
    Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
    [Abstract] [Full Text] [Related]

  • 20. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
    Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, Bosch J.
    Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.